Published in Medical Letter on the CDC and FDA, January 24th, 2000
Influenza is now occurring in many areas of the country, and health care professionals are confronted with therapeutic decisions for large numbers of patients with flu-like symptoms. Among other factors, they may consider whether to use 1 of the 4 drugs currently approved for antiviral therapy in uncomplicated influenza. Two of these, amantadine (Symmetrel and other brand names) and rimantadine (Flumadine), have been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.